All In MedTech

Device Trial Radar · NCT04078243

Feasibility of Novel Clinical Trial Infrastructure, Design and Technology for Early Phase Studies in Patients With Pulmonary Hypertension (FIT-PH)

Feasibility of Novel Clinical Trial Infrastructure, Design and Technology for Early Phase Studies in Patients With Pulmonary Hypertension.

Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Jan 21, 2020

Primary completion

Jan 6, 2028

Study completion Sep 6, 2028

Sponsor

Lead sponsor
Sheffield Teaching Hospitals NHS Foundation TrustAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 6, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, open-label, observational study to evaluate the safety and feasibility of using pulmonary artery pressure (PAP) monitors and wearable activity monitors in patients with pulmonary hypertension (PH).

Conditions

  • Pulmonary Hypertension

Interventions

  • CardioMEMS HF SystemDevice

    The CardioMEMS HF System is the first and only FDA-approved wireless heart failure monitor. The system is a safe, reliable way to help your patients manage their heart failure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Activity MonitorsTime frame: Through study completion - 30/03/2024

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sheffield Teaching Hospitals NHS Foundation Trust

    Sheffield, South Yorkshire, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.